SANTA CLARA, Calif., May 2, 2011 /PRNewswire/ -- NewCardio, Inc., (OTC BB: NWCI) a cardiac diagnostic technology provider, today announced its selection for the prestigious NYC Bright Lights Conference at the Le Parker Meridien Hotel in New York City. Bright Lights is the only conference of its kind with an exclusive focus on publicly traded companies with disruptive and market changing intellectual property (IP). NewCardio will present on May 10, 2011 at 9 a.m. ET.
NewCardio was selected from MDB's 2011 group of "Best and Brightest" small-cap companies, a group that is advancing some of today's most innovative and market-leading intellectual property (IP). It is one of the 40 public companies ranking in the 90th percentile for its respective technology leadership from more than 1,500 small-cap companies with granted U.S. patents, as rated by PatentVest, MDB's proprietary IP business intelligence platform.
Christopher Marlett, CEO at MDB Capital Group, comments, "It's a rare and exciting opportunity to have so many key players that are driving IP asset monetization together under one roof and we look forward to sharing NewCardio's cardiac diagnostic technology with other innovators and investors at the Bright Lights conference."
Bright Lights also features high-profile speakers including the top IP experts in the nation, such as David Kappos, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office (USPTO), who will be joining as a keynote speaker; in addition to Marshall Phelps, former head of Microsoft IP, and John Cronin, former head of IBM's Patent Factory, and Paul Ryan of Acacia Research.
The second annual Bright Lights Conference will take place on May 10 - 11th at the Le Parker Meridien Hotel in New York City. To learn more about the event, please visit: http://www.mdb.com.
Investors and other interested partie